Asprosin, a Fasting-Induced Glucogenic Protein Hormone

被引:433
作者
Romere, Chase [1 ]
Duerrschmid, Clemens [1 ]
Bournat, Juan [1 ]
Constable, Petra [1 ]
Jain, Mahim [2 ]
Xia, Fan [2 ]
Saha, Pradip K. [1 ]
Del Solar, Maria [6 ]
Zhu, Bokai [1 ]
York, Brian [1 ]
Sarkar, Poonam [3 ]
Rendon, David A. [3 ]
Gaber, M. Waleed [3 ]
LeMaire, Scott A. [4 ]
Coselli, Joseph S. [4 ]
Milewicz, Dianna M. [5 ]
Sutton, V. Reid [2 ]
Butte, Nancy F.
Moore, David D. [1 ]
Chopra, Atul R. [1 ,2 ]
机构
[1] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA
[3] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA
[4] Baylor Coll Med, Michael E DeBakey Dept Surg, Div Cardiothorac Surg, Houston, TX 77030 USA
[5] Univ Texas Med Sch Houston, Dept Internal Med, Houston, TX 77030 USA
[6] Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA
关键词
CONGENITAL LIPODYSTROPHY; MARFAN-SYNDROME; 3' END; MUTATION; FEATURES; MICE; SECRETION;
D O I
10.1016/j.cell.2016.02.063
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hepatic glucose release into the circulation is vital for brain function and survival during periods of fasting and is modulated by an array of hormones that precisely regulate plasma glucose levels. We have identified a fasting-induced protein hormone that modulates hepatic glucose release. It is the C-terminal cleavage product of profibrillin, and we name it Asprosin. Asprosin is secreted by white adipose, circulates at nanomolar levels, and is recruited to the liver, where it activates the G protein-cAMP-PKA pathway, resulting in rapid glucose release into the circulation. Humans and mice with insulin resistance show pathologically elevated plasma asprosin, and its loss of function via immunologic or genetic means has a profound glucose- and insulin-lowering effect secondary to reduced hepatic glucose release. Asprosin represents a glucogenic protein hormone, and therapeutically targeting it may be beneficial in type II diabetes and metabolic syndrome.
引用
收藏
页码:566 / 579
页数:14
相关论文
共 19 条
[1]  
Aronoff S.L., 2004, Diabetes Spectr., V17, P183, DOI DOI 10.2337/DIASPECT.17.3.183
[2]   BIOCHEMISTRY OF THE PROTEIN HORMONES [J].
BEHRENS, OK ;
BROMER, WW .
ANNUAL REVIEW OF BIOCHEMISTRY, 1958, 27 :57-100
[3]   Lipodystrophy: Syndrome of severe insulin resistance [J].
Bindlish, Shagun ;
Presswala, Lubaina S. ;
Schwartz, Frank .
POSTGRADUATE MEDICINE, 2015, 127 (05) :511-516
[4]   Islet α cells and glucagon-critical regulators of energy homeostasis [J].
Campbell, Jonathan E. ;
Drucker, Daniel J. .
NATURE REVIEWS ENDOCRINOLOGY, 2015, 11 (06) :329-338
[5]   Seipin ablation in mice results in severe generalized lipodystrophy [J].
Cui, Xin ;
Wang, Yuhui ;
Tang, Yin ;
Liu, Yixiao ;
Zhao, Liping ;
Deng, Jingna ;
Xu, Guoheng ;
Peng, Xingui ;
Ju, Shenghong ;
Liu, George ;
Yang, Hongyuan .
HUMAN MOLECULAR GENETICS, 2011, 20 (15) :3022-3030
[6]   ACUTE ORAL CALCIUM LOAD DECREASES PARATHYROID SECRETION AND SUPPRESSES TUBULAR PHOSPHATE LOSS IN LONG-TERM RENAL-TRANSPLANT RECIPIENTS [J].
DUMOULIN, G ;
HORY, B ;
NGUYEN, NU ;
HENRIET, MT ;
BRESSON, C ;
REGNARD, J ;
SAINTHILLIER, Y .
AMERICAN JOURNAL OF NEPHROLOGY, 1995, 15 (03) :238-244
[7]   Further Evidence for a Marfanoid Syndrome With Neonatal Progeroid Features and Severe Generalized Lipodystrophy Due to Frameshift Mutations Near the 3′ End of the FBN1 Gene [J].
Goldblatt, Jack ;
Hyatt, Jill ;
Edwards, Caitlin ;
Walpole, Ian .
AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2011, 155A (04) :717-720
[8]   Marfan Syndrome With Neonatal Progeroid Syndrome-Like Lipodystrophy Associated With a Novel Frameshift Mutation at the 3′ Terminus of the FBN1-Gene [J].
Graul-Neumann, Luitgard M. ;
Kienitz, Tina ;
Robinson, Peter N. ;
Baasanjav, Sevjidmaa ;
Karow, Benjamin ;
Gillessen-Kaesbach, Gabriele ;
Fahsold, Raimund ;
Schmidt, Hartmut ;
Hoffmann, Katrin ;
Passarge, Eberhard .
AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2010, 152A (11) :2749-2755
[9]   Progeroid Facial Features and Lipodystrophy Associated With a Novel Splice Site Mutation in the Final Intron of the FBN1 Gene [J].
Horn, Denise ;
Robinson, Peter N. .
AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2011, 155A (04) :721-724
[10]   Neonatal progeroid variant of Marfan syndrome with congenital lipodystrophy results from mutations at the 3′ end of FBN1 gene [J].
Jacquinet, Adeline ;
Verloes, Alain ;
Callewaert, Bert ;
Coremans, Christine ;
Coucke, Paul ;
de Paepe, Anne ;
Kornak, Uwe ;
Lebrun, Frederic ;
Lombet, Jacques ;
Pierard, Gerald E. ;
Robinson, Peter N. ;
Symoens, Sofie ;
Van Maldergem, Lionel ;
Debray, Francois-Guillaume .
EUROPEAN JOURNAL OF MEDICAL GENETICS, 2014, 57 (05) :230-234